RBM4B
RNA-binding protein 4B
Also known as: MGC10871, RBM30, RBM4B_HUMAN, RBM4L, ZCCHC15, ZCCHC21B, ZCRB3B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BQ04
- Gene
- RBM4B
- Ensembl
- ENSG00000173914
- Chromosome
- 11
- Canonical length
- 359 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables RNA binding activity. Predicted to be involved in circadian regulation of gene expression; entrainment of circadian clock by photoperiod; and regulation of translation. Predicted to act upstream of or within positive regulation of gene expression. Located in cytosol and nucleoplasm. Part of protein-containing complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
359 residues, UniProt reviewed canonical sequence.
>Q9BQ04|RBM4B
1 MVKLFIGNLP REATEQEIRS LFEQYGKVLE CDIIKNYGFV HIEDKTAAED AIRNLHHYKL
61 HGVNINVEAS KNKSKASTKL HVGNISPTCT NQELRAKFEE YGPVIECDIV KDYAFVHMER
121 AEDAVEAIRG LDNTEFQGKR MHVQLSTSRL RTAPGMGDQS GCYRCGKEGH WSKECPVDRT
181 GRVADFTEQY NEQYGAVRTP YTMGYGESMY YNDAYGALDY YKRYRVRSYE AVAAAAAASA
241 YNYAEQTMSH LPQVQSTTVT SHLNSTSVDP YDRHLLPNSG AAATSAAMAA AAATTSSYYG
301 RDRSPLRRAA AMLPTVGEGY GYGPESELSQ ASAATRNSLY DMARYEREQY VDRARYSAFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBM4B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 42 nTPM
- retina: 32 nTPM
- ovary: 26 nTPM
- pituitary gland: 23 nTPM
- cervix: 23 nTPM
- spinal cord: 22 nTPM
Single-cell type
- cardiomyocytes: 166 nCPM
- myonuclei: 120 nCPM
- rod photoreceptor cells: 92 nCPM
- early primary spermatocytes: 79 nCPM
- epicardial cells: 75 nCPM
- late spermatids: 72 nCPM
Immune cell
- eosinophil: 44 nTPM
- memory B-cell: 35 nTPM
- naive B-cell: 29 nTPM
- basophil: 26 nTPM
- non-classical monocyte: 26 nTPM
- intermediate monocyte: 23 nTPM
Brain region
- cerebellum: 53 nTPM
- cerebral cortex: 39 nTPM
- white matter: 38 nTPM
- hypothalamus: 35 nTPM
- basal ganglia: 31 nTPM
- amygdala: 31 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.67
- DepMap mean gene effect
- -0.28
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- circadian regulation of gene expression
- circadian rhythm
- entrainment of circadian clock by photoperiod
- mRNA processing
- positive regulation of gene expression
- regulation of alternative mRNA splicing, via spliceosome
- regulation of translation
- RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBM4B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBM4B as an antibody target. Whether an autoantibody or antibody against RBM4B could matter depends on whether native RBM4B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBM4B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBM4B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...